pamidronate has been researched along with Fever in 9 studies
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous injection of 4 mg zoledronic acid can significantly reduce bone pain and bone resorption marker in urine in the Chinese patients with bone metastasis from solid tumor or multiple myeloma, which is tolerable and also comparable to pamidronate in the efficacy and safety." | 9.13 | [Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma]. ( Chen, Q; Dong, M; Feng, FY; Feng, JF; Jiao, SC; Li, J; Liu, JW; Ren, J; Song, ST; Wang, XW; Wang, YJ; Wang, ZH; Xie, GR; Xu, N; Zhang, Y; Zhou, QH, 2008) |
| "Nine infants and young children with osteogenesis imperfecta (age range 1-35 months) were treated with intravenous pamidronate." | 9.11 | Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. ( DiMeglio, LA; Ford, L; McClintock, C; Peacock, M, 2004) |
| "Clinical studies showed that pamidronate has curative effects on pain induced by bone metastasis." | 9.11 | [Pamidronate in treatment of pain caused by bone metastasis]. ( Cai, Y; Chen, YL; Liu, HQ; Liu, MZ; Ren, J; Wang, DJ; Zhan, QY, 2004) |
| "Intravenous injection of 4 mg zoledronic acid can significantly reduce bone pain and bone resorption marker in urine in the Chinese patients with bone metastasis from solid tumor or multiple myeloma, which is tolerable and also comparable to pamidronate in the efficacy and safety." | 5.13 | [Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma]. ( Chen, Q; Dong, M; Feng, FY; Feng, JF; Jiao, SC; Li, J; Liu, JW; Ren, J; Song, ST; Wang, XW; Wang, YJ; Wang, ZH; Xie, GR; Xu, N; Zhang, Y; Zhou, QH, 2008) |
| "Nine infants and young children with osteogenesis imperfecta (age range 1-35 months) were treated with intravenous pamidronate." | 5.11 | Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. ( DiMeglio, LA; Ford, L; McClintock, C; Peacock, M, 2004) |
| "Clinical studies showed that pamidronate has curative effects on pain induced by bone metastasis." | 5.11 | [Pamidronate in treatment of pain caused by bone metastasis]. ( Cai, Y; Chen, YL; Liu, HQ; Liu, MZ; Ren, J; Wang, DJ; Zhan, QY, 2004) |
| "Pamidronate is a second-generation bisphosphonate that undergoes negligible biodegradation and is eliminated exclusively by renal excretions." | 1.30 | Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function. ( Berenson, JR; Knight, RD; Kowalski, MO; Lau, HS; Rosen, L; Seaman, JJ; Sioufi, A; Vescio, R; Woo, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, KC | 1 |
| Ferguson, BM | 1 |
| Dong, M | 1 |
| Feng, FY | 1 |
| Zhang, Y | 1 |
| Xie, GR | 1 |
| Wang, YJ | 1 |
| Liu, JW | 1 |
| Song, ST | 1 |
| Zhou, QH | 1 |
| Ren, J | 2 |
| Jiao, SC | 1 |
| Li, J | 1 |
| Wang, XW | 1 |
| Chen, Q | 1 |
| Wang, ZH | 1 |
| Xu, N | 1 |
| Feng, JF | 1 |
| DiMeglio, LA | 1 |
| Ford, L | 1 |
| McClintock, C | 1 |
| Peacock, M | 1 |
| Wang, DJ | 1 |
| Liu, HQ | 1 |
| Chen, YL | 1 |
| Zhan, QY | 1 |
| Cai, Y | 1 |
| Liu, MZ | 1 |
| Heynen, G | 1 |
| Delwaide, P | 1 |
| Bijvoet, OL | 1 |
| Franchimont, P | 1 |
| Berenson, JR | 1 |
| Rosen, L | 1 |
| Vescio, R | 1 |
| Lau, HS | 1 |
| Woo, M | 1 |
| Sioufi, A | 1 |
| Kowalski, MO | 1 |
| Knight, RD | 1 |
| Seaman, JJ | 1 |
| Buckler, HM | 1 |
| Mercer, SJ | 1 |
| Davison, CE | 1 |
| Hollis, S | 1 |
| Richardson, PC | 1 |
| Anderson, DG | 1 |
| Phanish, MK | 1 |
| Kallarackal, G | 1 |
| Ravanan, R | 1 |
| Lawson, TM | 1 |
| Baboolal, K | 1 |
| Gallacher, SJ | 1 |
| Ralston, SH | 1 |
| Patel, U | 1 |
| Boyle, IT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for pamidronate and Fever
| Article | Year |
|---|---|
[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].
Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Collage | 2008 |
Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
Topics: Alkaline Phosphatase; Amino Acids; Anti-Inflammatory Agents; Bone Density; Calcium; Child, Preschool | 2004 |
[Pamidronate in treatment of pain caused by bone metastasis].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Dose-Response Relationship, Drug; Fem | 2004 |
Evaluation of adverse experiences related to pamidronate infusion in Paget's disease of bone.
Topics: Aged; Anti-Inflammatory Agents; Diphosphonates; Double-Blind Method; Female; Fever; Headache; Humans | 1998 |
5 other studies available for pamidronate and Fever
| Article | Year |
|---|---|
Elderly man with mandibular pain.
Topics: Abscess; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Drainage; Fever; Humans; Mal | 2019 |
Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcium; Diphosphonates; Fever; Humans; Hydroxyproline; Osteitis Deformans; Pa | 1982 |
Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function.
Topics: Aged; Aged, 80 and over; Area Under Curve; Diphosphonates; Female; Fever; Headache; Humans; Male; Me | 1997 |
Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a haemodialysis patient: successful treatment using intravenous pamidronate.
Topics: Adult; Anti-Inflammatory Agents; Arthritis; C-Reactive Protein; Calcinosis; Diphosphonates; Fever; H | 2000 |
Side-effects of pamidronate.
Topics: Diphosphonates; Fever; Humans; Infusions, Intravenous; Pamidronate; Time Factors | 1989 |